Interstitial lung diseases (ILDs) encompass more than 100 conditions. They represent a heterogeneous group of acute or chronic lung diseases that are characterized—to varying degrees—by inflammation and uncontrolled connective tissue formation, leading to scarring and stiffening of the lungs. The initial presentation of IPF is insidious dyspnea on exertion and a dry cough; the prognosis is poor.
Autoren
- Melika Piric
- Prof. Dr. med. Philipp Markart
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Biophilic Design of Work Environments
Effects on Health, Well-Being, and Productivity
- From symptom to diagnosis
Intrapelvic mass with an ambiguous differential diagnosis
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle
Surgical Challenges and Recurrence Patterns
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Alcohol Consumption While Taking Semaglutide
Withdrawal Symptoms Thanks to GLP-1 RA?
- Why Echocardiography Has Redefined the Clinical Picture